PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS, page-77

  1. 9,839 Posts.
    lightbulb Created with Sketch. 1258
    FOMO may set in given it could replace current standard of care.

    Retreatment at 12 months is likely once we see this clinically tested

    Retreated patients will in all likelihood provide >$ than initial (new) treated patients within 5 years of release.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.